KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Total Debt (2019 - 2025)

GoodRx Holdings (GDRX) has disclosed Total Debt for 7 consecutive years, with $488.3 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 0.7% to $488.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $488.3 million through Dec 2025, down 0.7% year-over-year, with the annual reading at $488.3 million for FY2025, 0.7% down from the prior year.
  • Total Debt hit $488.3 million in Q4 2025 for GoodRx Holdings, roughly flat from $489.1 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $665.9 million in Q1 2021 to a low of $488.3 million in Q4 2025.
  • Historically, Total Debt has averaged $608.7 million across 5 years, with a median of $656.6 million in 2023.
  • Biggest five-year swings in Total Debt: decreased 0.35% in 2023 and later fell 25.1% in 2024.
  • Year by year, Total Debt stood at $662.9 million in 2021, then fell by 0.61% to $658.8 million in 2022, then decreased by 0.35% to $656.5 million in 2023, then dropped by 25.1% to $491.7 million in 2024, then fell by 0.7% to $488.3 million in 2025.
  • Business Quant data shows Total Debt for GDRX at $488.3 million in Q4 2025, $489.1 million in Q3 2025, and $490.0 million in Q2 2025.